My bookmarks

Pins are saved using cookies. Deleting them from your browser will delete your preferences.

Menu
News 

A vital sign for healthcare

10 January 2017

Current discount plus growth potential creates opportunity

The underperforming Healthcare sector is likely poised for a turnaround. The last time the sector's valuation discount to the market was this wide, it outperformed the S&P 500 bu over 700 basis points annually over the subsequent five years.

  • The last time the current discount was this large was early 2011. However, the sector may now be propelled upward by tailwinds. Under the new administration, the likelihood of new legislation controlling the pricing of drugs and healthcare services is severely diminished.
    • Within the Healthcare sector, innovation in drug discovery and development offers attractive investment opportunities including drug makers and the companies that service them— those that sell tools, materials, or software.
    • There will be an increased need for services with an aging population that requires more medical care.
La Française Group provides access to the expertise of a number of <a href="en/regulatory-information/" target="_blank">asset management companies</a> around the world. To provide you with the most relevant information, we have developed an interface to present the full range of products available for your investor profile and country of residence.

Present yourself

1
Country
2
Language
3
Profile

Your country of residence

Your language

Your profile

<p class="new-disclaimer__legal-notice">Before consulting this website, for your protection and in your interest, please read the “<a href="en/legal-notice/" target="_blank">disclaimer</a>” and “<a href="en/regulatory-information/" target="_blank">current regulations</a>” carefully. This information explains certain legal and regulatory restrictions which apply to individual and professional investors according to local law. By accessing this site, in my non-professional or professional capacity, I acknowledge that I have read and accept the terms and conditions of use. Pursuant to the application of the European Markets in Financial Instruments Directive (“MiFID”), please state to which category of investor you belong&nbsp;:</p>
<p class="new-disclaimer__legal-notice">Before consulting this website, for your protection and in your interest, please read the “<a href="en/legal-notice/" target="_blank">disclaimer</a>” and “<a href="en/regulatory-information/" target="_blank">current regulations</a>” carefully. This information explains certain legal and regulatory restrictions which apply to individual and professional investors according to local law. By accessing this site, in my non-professional or professional capacity, I acknowledge that I have read and accept the terms and conditions of use. Pursuant to the application of the European Markets in Financial Instruments Directive (“MiFID”), please state to which category of investor you belong&nbsp;:</p>
By continuing browsing on this website, you accept the use of cookies and other tracing devices s as to allow you to receive information suited to your profile, facilitate information sharing on social networks, guarantee the best browsing experience possible and to create statistics. To find out more, we invite you to consult our Privacy and Cookies policy. Find out more.